R&D
NICE queries pharma R&D costs
September 5, 2013Research and Development, Sales and Marketing Dillon, NICE, Pfizer, R&D
NICE has questioned whether pharma really spends as much as it says it does on bringing new treatments to market …
Ipsen buys Syntaxin
July 16, 2013Research and Development, Sales and Marketing R&D, ipsen, neurology, syntaxin, tsi
French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …
Sanofi makes Curie cancer deal
June 20, 2013Research and Development, Sales and Marketing Cancer, R&D, Sanofi, curie
Sanofi has signed a three-year research collaboration with the Curie Institute to identify new therapeutic targets which will help develop …
John LaMattina: India’s solution to drug costs
May 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, LaMattina, R&D
Drug pricing is a major issue in India. The Indian government believes that the prices of lifesaving drugs shouldn’t be …
AstraZeneca reveals Alderley Park plan
May 8, 2013Research and Development, Sales and Marketing AstraZeneca, BioCity, R&D, alderley
AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …
Pharma R&D ‘untenable’
April 25, 2013Research and Development, Sales and Marketing GlobalData, R&D
The current model by which pharma carries out R&D is ‘untenable’, according to a new report. But the research, from …
AstraZeneca sets out growth strategy
March 21, 2013Sales and Marketing AstraZeneca, R&D
AstraZeneca has set out an ambitious plan designed to return it to growth which eschews diversification and sets great store …
AstraZeneca restructures global R&D
March 19, 2013Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, R&D
AstraZeneca is restructuring its global operations in a bid to improve the productivity of its R&D operations. The firm is …
NHS patient data and clinical research – coming together at last?
January 28, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, NHS, R&D, clinical, records, transparency
In the mid-1990s, an NHS teaching hospital close to my offices invited proposals for expanding its clinical trials unit. Hitherto …
Vaccine manufacturing emerges as outsourcing market
January 28, 2013Manufacturing and Production R&D, Vaccine, outsourcing
Healthy growth in the market for vaccines – coupled with high production costs – look set to create a vaccine …
AstraZeneca shakes up management
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Mackay, R&D, Soriot
AstraZeneca has taken its most dramatic steps yet to arrest decline, with chief executive Pascal Soriot axeing two senior positions …
R&D costs rise ten-fold
December 4, 2012Research and Development, Sales and Marketing OHE, R&D, research and development
Research by the Office of Health Economics (OHE) think tank shows that the cost of pharma R&D has risen ten-fold …
UK medicine costs ‘under control’
October 24, 2012Sales and Marketing ABPI, PCT, R&D, UK medicine
The ABPI has seized on two reports – one its own and one independent – published this week to assert …
Turkey ‘can be pharma R&D, production hub by 2023’, says PwC
October 23, 2012Manufacturing and Production, Research and Development, Sales and Marketing R&D, Turkey, pwC
Despite lagging behind its peers among ‘pharmerging’ economies, Turkey has the potential to become a major R&D and production hub …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
